Farenta merges into Oriola for better customer experience
Farenta´s expert services for pharmaceutical companies have been an important part of Oriola´s Nordic service portfolio since 2016. We provide the most extensive range of high-quality services in the field, covering the entire lifespan of a medicine: from clinical trials to market access services, from medical translations to marketing authorisations, from pharmaceutical logistics to sales and marketing services, and from medical information to pharmacovigilance and patient support services.
In the end of October 2019, Farenta will merge into Oriola. The merger helps us to serve our customers even better and enables a fluent Nordic level collaboration.
Nordic service offering for pharmaceutical companies
At Oriola, we develop individual and comprehensive solutions to enhance our customers’ growth, profitability and efficiency.
“Through our strong market knowledge and expertise, we are a trusted and strategic partner for our customers. Together with my team, we are committed to help our customers to succeed in the Nordic pharmaceutical market”, says Fredrik Pamp, Sales and Marketing Director, Business Area Pharma.
The evolving needs of pharmaceutical companies, social development and digitalisation are topics that we constantly discuss with our customers. They create interesting opportunities that we can take hold of together.
“In our vision, we are the caring enabler for a healthier tomorrow. To support wellbeing in the society, we aim to find innovative solutions for our customers. Our internationally unique Real World Evidence study concept is a fantastic example of this”, says Mikko Törmä, founder of Farenta and current director of Oriola's expert services.